IG 281 Pill - pink round, 11mm
Pill with imprint IG 281 is Pink, Round and has been identified as Topiramate 200 mg. It is supplied by InvaGen Pharmaceuticals, Inc.
Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Epilepsy; Seizure Prevention; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IG 281
Topiramate
- Imprint
- IG 281
- Strength
- 200 mg
- Color
- Pink
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- InvaGen Pharmaceuticals, Inc.
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
corn starch,
sodium starch glycolate type A potato,
magnesium stearate,
silicon dioxide,
hypromellose 2910 (6 mPa.s),
polyethylene glycol 400,
ferric oxide red
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 31722-0281 | Camber Pharmaceuticals, Inc. |
| 60429-0772 | Golden State Medical Supply (repackager) |
Related images for "IG 281"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,337)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
Other brands
Topamax, Trokendi XR, Eprontia, Topiragen, Qudexy XR
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Oral Solution (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.